Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Nov 26, 2023 8:32pm
142 Views
Post# 35753724

RE:RE:RE:Options

RE:RE:RE:Options
OMG Canada fan you might be on to something, they always hang on to all of their shares .
Let's see and just for fun the ownership. before kirk just bought his shares and this is from the a recent agm circular.

Ownership of shares by the execs at ONC.
Matt Coffey-82,659 shares
Kirk Look- 33,028 shares
Thomas Heineman-00000000 shares
Andrew de Guttadairp 10,315 shares
Allison Hagerman-000000 shares

So if you want to tell the whole story then let's tell the whole story and you gotta own or have shares to be able to sell them so yes your statement is true but does not paint a true picture of exactly the ownership stake that management has in the company.

So how many people on these boards have more of a stake at risk than any of the managment. HMMM.

So wow , good thing managment did not sell all of their shares as that would have sent a bad message to everyone
<< Previous
Bullboard Posts
Next >>